HWKN - Hawkins - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4202611095

Chemicals, Ingredients, Industrial, Water Treatment, Nutritional Products

Hawkins, Inc. is a specialty chemical and ingredients company that operates in the United States, catering to a diverse range of industries through its three business segments: Industrial, Water Treatment, and Health and Nutrition.

The Industrial segment is a significant contributor to the company's revenue, offering a wide array of industrial chemicals, products, and services to various industries such as agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating. This segment manufactures a range of products, including sodium hypochlorite, agricultural products, food-grade and pharmaceutical products, and blended products. Additionally, it receives, stores, and distributes various chemicals, including liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. The segment also provides value-added services such as repackaging of water treatment chemicals and bulk industrial chemicals, as well as custom blending of chemicals.

The Water Treatment segment is focused on providing chemicals, products, equipment, services, and solutions for various water treatment applications, including potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agriculture water. This segment plays a critical role in ensuring the quality and safety of water for various industries and communities.

The Health and Nutrition segment is a key player in the ingredient distribution, processing, and formulation solutions space, catering to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement, and other nutritional food and health and wellness products. The segment's product portfolio is diverse, including minerals, vitamins and amino acids, excipients, joint products, botanicals and herbs, sweeteners, and enzymes. Hawkins, Inc. is well-positioned to capitalize on the growing demand for healthy and nutritious products.

Founded in 1938, Hawkins, Inc. has a rich history and a strong reputation in the industry. Headquartered in Roseville, Minnesota, the company has established itself as a reliable partner for its customers, providing high-quality products and services that meet their specific needs. For more information, visit https://www.hawkinsinc.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for HWKN - Hawkins  - Stock Price & Dividends

HWKN Stock Overview

Market Cap in USD 2,043m
Sector Basic Materials
Industry Specialty Chemicals
GiC SubIndustry Commodity Chemicals
TER 0.00%
IPO / Inception 1993-10-27

HWKN Stock Ratings

Growth 5y 93.8
Fundamental 74.6
Dividend 58.1
Rel. Performance vs Sector 3.58
Analysts 4.00/5
Fair Price Momentum 144.25 USD
Fair Price DCF 149.91 USD

HWKN Dividends

Dividend Yield 12m 0.60%
Yield on Cost 5y 3.16%
Dividends CAGR 5y 6.15%
Payout Consistency 98.4%

HWKN Growth Ratios

Growth 12m 131.59%
Growth Correlation 12m 82%
Growth Correlation 3m 77%
CAGR 5y 39.44%
CAGR/Mean DD 5y 4.05
Sharpe Ratio 12m 3.47
Alpha vs SP500 12m 115.66
Beta vs SP500 5y weekly 0.68
ValueRay RSI 84.82
Volatility GJR Garch 1y 35.06%
Price / SMA 50 16.57%
Price / SMA 200 45.04%
Current Volume 113.3k
Average Volume 20d 134.9k

External Links for HWKN Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of HWKN stocks?
As of July 27, 2024, the stock is trading at USD 107.01 with a total of 113,281 shares traded.
Over the past week, the price has changed by +1.74%, over one month by +20.41%, over three months by +41.47% and over the past year by +131.10%.
What are the forecast for HWKN stock price target?
According to ValueRays Forecast Model, HWKN Hawkins will be worth about 159 in July 2025. The stock is currently trading at 107.01. This means that the stock has a potential upside of +48.54%.
Issuer Forecast Upside
Wallstreet Target Price 96.5 -9.82
Analysts Target Price 62 -42.1
ValueRay Target Price 159 48.5